[Immediate results of the clinical use of bruneomycin].
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001772:Blood Cell Count; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008080:Liposarcoma / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D013724:Teratoma / Q000188:drug therapy; D014067:Tonsillar Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic
Neprosredstvennye rezul'taty klinicheskogo primeneniia bruneomitsina.